COST-EFFECTIVENESS ANALYSIS OF TREATING ACUTE CORONARY SYNDROME PATIENTS WITH TICAGRELOR VERSUS CLOPIDOGREL IN HONG KONG: A MARKOV ANALYTIC MODEL

被引：0
|
作者：
Lee, V. W. Y. [1 ]
Chow, I. H. I. [1 ]
Yan, B. P. [2 ,3 ]
Yu, C. M. [1 ]
Lam, Y. Y. [1 ]
机构：
[1] Chinese Univ Hong Kong, Shatin, Hong Kong, Peoples R China
[2] Prince Wales Hosp, Hong Kong, Hong Kong, Peoples R China
[3] Monash Univ, Hong Kong, Hong Kong, Peoples R China
来源：
VALUE IN HEALTH | 2012年 / 15卷 / 07期
关键词：
D O I：
10.1016/j.jval.2012.08.993
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：A371 / A371
页数：1
相关论文
共 50 条
  • [21] Cost-effectiveness of prasugrel versus clopidogrel in acute coronary syndrome patients undergoing percutaneous coronary intervention
    Spartalis, Michael
    Tzatzaki, Eleni
    Nikiteas, Nikolaos I.
    Spartalis, Eleftherios
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2018, 251 : 32 - 32
  • [22] A COST-EFFECTIVENESS ANALYSIS OF CLOPIDOGREL IN PATIENTS WITH NON STABLE ACUTE CORONARY SYNDROME IN GREECE
    Kourlaba, G.
    Fragoulakis, V
    Maniadakis, N.
    VALUE IN HEALTH, 2011, 14 (07) : A377 - A378
  • [23] Ticagrelor versus clopidogrel in Chinese patients with acute coronary syndrome: A pharmacodynamic analysis
    Chen, Yundai
    Dong, Wei
    Wan, Zheng
    Li, Zhanquan
    Cong, Hongliang
    Hong, Tao
    Yin, Tong
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2015, 201 : 545 - 546
  • [24] Cost-effectiveness of treating acute coronary syndrome patients with ticagrelor for 12 months: results from the PLATO study
    Nikolic, Elisabet
    Janzon, Magnus
    Hauch, Ole
    Wallentin, Lars
    Henriksson, Martin
    EUROPEAN HEART JOURNAL, 2013, 34 (03) : 220 - 228
  • [25] COST-EFFECTIVENESS ANALYSIS OF PRASUGREL, CLOPIDOGREL AND TICAGRELOR IN DUAL ANTIPLATELET THERAPY ON PATIENTS WITH ACUTE CORONARY SYNDROME IN AUSTRIA BETWEEN 2009 AND 2014
    Marchev, S.
    Rezaei, Sheikh S.
    Geroldinger, A.
    Heinze, G.
    Reichardt, B.
    Wolzt, M.
    VALUE IN HEALTH, 2020, 23 : S97 - S97
  • [26] COST-EFFECTIVENESS OF TREATING ACUTE CORONARY SYNDROME PATIENTS WITH RIVAROXBAN IN AUSTRALIA
    Gao, L.
    Li, S. C.
    VALUE IN HEALTH, 2014, 17 (07) : A760 - A760
  • [27] A cost analysis in patients with acute coronary syndrome using clopidogrel in addition to aspirin in a Hong Kong Public Hospital
    Lee, Vivian W. Y.
    Chan, Wai Kwong
    Lee, Kenneth K. C.
    INTERNATIONAL HEART JOURNAL, 2006, 47 (05) : 739 - 744
  • [28] A cost-effectiveness and safety analysis of dual antiplatelet therapy comparing aspirin-clopidogrel to aspirin-ticagrelor in patients with acute coronary syndrome
    Nafrialdi
    Handini, Novita M.
    Instiaty
    Wijaya, Ika P.
    MEDICAL JOURNAL OF INDONESIA, 2018, 27 (04) : 262 - 270
  • [29] Cost-effectiveness of ticagrelor in acute coronary syndromes
    Henriksson, Martin
    Janzon, Magnus
    EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH, 2013, 13 (01) : 9 - 18
  • [30] LONG-TERM COST-EFFECTIVENESS OF TICAGRELOR IN PATIENTS WITH ACUTE CORONARY SYNDROME IN THAILAND
    Permsuwan, U.
    Yamwong, S.
    Tinmanee, S.
    Sritara, P.
    VALUE IN HEALTH, 2012, 15 (07) : A633 - A633
12345